Equitable Holdings Reports Strong Q1 Earnings with 25% Operating EPS Growth, Reaffirms Corebridge Merger Accretion
summarizeSummary
Equitable Holdings announced robust first-quarter 2026 financial results, with net income soaring and Non-GAAP operating earnings per share increasing by 25% year-over-year, while also reiterating the expected immediate accretion from its Corebridge Financial merger.
check_boxKey Events
-
Strong Q1 Financial Performance
Net income rose to $621 million from $63 million year-over-year, and Non-GAAP operating earnings per share increased 25% to $1.62.
-
Shareholder Capital Return
The company returned $223 million to shareholders in Q1 2026, comprising $76 million in quarterly cash dividends and $147 million in share repurchases.
-
Positive Merger Outlook
Management reiterated that the pending all-stock merger with Corebridge Financial is expected to be immediately accretive to earnings per share and cash generation.
-
Asset Growth & Inflows
Total Assets Under Management/Administration (AUM/A) grew 9% year-over-year to $1.1 trillion, driven by net inflows of $1.3 billion in Retirement and $2.0 billion in Wealth Management.
auto_awesomeAnalysis
Equitable Holdings delivered a strong first quarter, significantly boosting net income and Non-GAAP operating earnings per share. This robust performance, coupled with continued capital returns to shareholders, signals healthy operational momentum. The reaffirmation of the Corebridge Financial merger's immediate accretive impact on earnings and cash generation provides a clear positive catalyst, reinforcing the company's strategic growth trajectory. Investors should view these results as a strong indicator of the company's financial health and future prospects, especially as the Corebridge integration progresses.
At the time of this filing, EQH was trading at $42.40 on NYSE in the Finance sector, with a market capitalization of approximately $11.7B. The 52-week trading range was $35.20 to $56.61. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.